Table 1 Clinical data for patients who underwent primary surgery
n | M30 positive DTC | p-value | |
|---|---|---|---|
N = 298 | (%) | ||
Total | 298 | 82 (27) | |
Menopausal status | n.s. | ||
Premenopausal | 63 | 14 (22) | |
Postmenopausal | 235 | 68 (29) | |
Tumor size | n.s. | ||
pT1 | 204 | 57 (28) | |
pT2-4 | 94 | 25 (27) | |
Nodal status | n.s. | ||
Negative | 214 | 54 (25) | |
Positive | 84 | 28 (33) | |
Histology | n.s. | ||
Ductal | 226 | 63 (28) | |
Lobular | 54 | 16 (30) | |
Others | 18 | 3 (17) | |
Grading | n.s. | ||
I/II | 268 | 74 (28) | |
III | 30 | 8 (27) | |
ER status | n.s. | ||
Negative | 45 | 12 (27) | |
Positive | 253 | 70 (28) | |
PR status | n.s. | ||
Negative | 53 | 11 (21) | |
Positive | 245 | 71 (29) | |
HER2 status | n.s. | ||
Negative | 232 | 69 (30) | |
Positive | 52 | 12 (23) |